Wow! A 14.16% Dividend Yield with 32.67% in upside potential?

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Pharma Stock: 1,788% Upside?]( [Click Here for Symbol.]( --------------------------------------------------------------- March 27, 2023 From the desk of the Editor Dear Reader, We have identified several stocks which are expected to go “Ex-Dividend” very soon. If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. So please keep this in mind. Below is our latest Dividend Report: --------------------------------------------------------------- Sponsor Message [FDA news shines light on this little-known clinical-stage Pharma]( Reader, This little-known clinical-stage pharma company recently received a favorable decision from the FDA and it's shining a light on its potential for significant growth. Could we be looking at 1,788% in upside potential? Free report reveals the name, ticker symbol, and 14 reasons to immediately start your research on this company. Don’t miss out on this one... [Click Here For Free Report]( --------------------------------------------------------------- [Tpg Re Finance]( Symbol: [TRTX]( Recent Price: $7.07 Average Analyst Price Target: $9.38 (32.67%) Market Cap: $547.29M Expected Ex-Dividend Date: Mar 28 2023 Expected Payment Date: Apr 25 2023 Expected Dividend & Yield: 14.16% Recent Analyst Action: Arren Cyganovich, analyst at Citigroup, reiterates coverage on [Tpg Re Finance (TRTX)]( in the Financial sector with a Hold rating and a price target of $9.00 (1 month ago). [TipRanks.com]( also reports that [Tpg Re Finance]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $9.38. The target pricing ranges from a high forecast of $11.00 down to a low forecast of $8.50. [Tpg Re Finance (TRTX)](’s last closing price was $7.07 which would put the average price target at 32.67% upside. Here are 3rd party ratings for [TRTX](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 32% (171 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Forever Battery: Making Gas Guzzlers Obsolete]( 2% of cars sold in the U.S. today are electric vehicles… but that’s about to change — FAST. A new battery breakthrough is ready to hit the market. It could revolutionize the $2 trillion automotive industry … and could soon make gas guzzlers obsolete. This technology is predicted to cause a 1,500% surge in electric vehicle sales over the next four years. The company pioneering this new battery could be the investment of a lifetime. [Click here for details.]( --------------------------------------------------------------- [Zimmer Biomet Holdings]( Symbol: [ZBH]( Recent Price: $126.04 Average Analyst Price Target: $137.60 (9.17%) Market Cap: $26.48B Expected Ex-Dividend Date: Mar 28 2023 Expected Payment Date: Apr 28 2023 Expected Dividend & Yield: 0.77% Recent Analyst Action: Matthew O'Brien, analyst at Piper Sandler, reiterates coverage on [Zimmer Biomet Holdings (ZBH)]( in the Healthcare sector with a Buy rating and a price target of $145.00 (2 weeks ago). [TipRanks.com]( also reports that [Zimmer Biomet Holdings]( currently has 17 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $137.60. The target pricing ranges from a high forecast of $150.00 down to a low forecast of $115.00. [Zimmer Biomet Holdings (ZBH)](’s last closing price was $126.04 which would put the average price target at 9.17% upside. Here are 3rd party ratings for [ZBH](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 40% (149 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Guess?, Inc.]( Symbol: [GES]( Recent Price: $17.98 Average Analyst Price Target: $23.00 (27.92%) Market Cap: $978.97M Expected Ex-Dividend Date: Mar 28 2023 Expected Payment Date: Apr 14 2023 Expected Dividend & Yield: 4.96% Recent Analyst Action: Dana Telsey, analyst at Telsey Advisory, reiterates coverage on [Guess?, Inc. (GES)]( in the Consumer Goods sector with a Hold rating and a price target of $23.00 (1 week ago). [TipRanks.com]( also reports that [Guess?, Inc.]( currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $23.00. The target pricing ranges from a high forecast of $23.00 down to a low forecast of $23.00. [Guess?, Inc. (GES)](’s last closing price was $17.98 which would put the average price target at 27.92% upside. Here are 3rd party ratings for [GES](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Strong Sell, Bottom 42% (145 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Mercer International]( Symbol: [MERC]( Recent Price: $9.57 Average Analyst Price Target: $13.50 (41.07%) Market Cap: $633.22M Expected Ex-Dividend Date: Mar 28 2023 Expected Payment Date: Apr 05 2023 Expected Dividend & Yield: 3.17% Recent Analyst Action: Paul Quinn, analyst at RBC Capital, reiterates coverage on [Mercer International (MERC)]( in the Basic Materials sector with a Hold rating and a price target of $12.00 (1 month ago). [TipRanks.com]( also reports that [Mercer International]( currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $13.50. The target pricing ranges from a high forecast of $15.50 down to a low forecast of $12.00. [Mercer International (MERC)](’s last closing price was $9.57 which would put the average price target at 41.07% upside. Here are 3rd party ratings for [MERC](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Bottom 28% (181 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Conocophillips]( Symbol: [COP]( Recent Price: $95.43 Average Analyst Price Target: $139.20 (45.87%) Market Cap: $116.31B Expected Ex-Dividend Date: Mar 28 2023 Expected Payment Date: Apr 14 2023 Expected Dividend & Yield: 2.01% Recent Analyst Action: Jeanine Wai, analyst at Barclays, reiterates coverage on [Conocophillips (COP)]( in the Utilities sector with a Buy rating and a price target of $141.00 (4 days ago). [TipRanks.com]( also reports that [Conocophillips]( currently has 16 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $139.20. The target pricing ranges from a high forecast of $156.00 down to a low forecast of $102.00. [Conocophillips (COP)](’s last closing price was $95.43 which would put the average price target at 45.87% upside. Here are 3rd party ratings for [COP](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 38% (156 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Biden To Unleash "Choke Point" Operation On America?]( s disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now. [Get The Rest Of The Details Here]( --------------------------------------------------------------- [Armada Hoffler Properties]( Symbol: [AHH]( Recent Price: $11.27 Average Analyst Price Target: $16.00 (41.97%) Market Cap: $995.42M Expected Ex-Dividend Date: Mar 28 2023 Expected Payment Date: Apr 06 2023 Expected Dividend & Yield: 6.59% Recent Analyst Action: Christopher Sakai, analyst at Singular, reiterates coverage on [Armada Hoffler Properties (AHH)]( in the Financial sector with a Buy rating and a price target of $18.00 (1 month ago). [TipRanks.com]( also reports that [Armada Hoffler Properties]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.00. The target pricing ranges from a high forecast of $18.00 down to a low forecast of $14.00. [Armada Hoffler Properties (AHH)](’s last closing price was $11.27 which would put the average price target at 41.97% upside. Here are 3rd party ratings for [AHH](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 31% (172 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Klepierre (ex Compagnie Fonciere Klepierre)]( Symbol: [KLPEF]( Recent Price: $22.04 Average Analyst Price Target: $26.77 (21.47%) Market Cap: $6.28B Expected Ex-Dividend Date: Jul 07 2023 Expected Payment Date: Jul 11 2023 Expected Dividend & Yield: 8.12% Recent Analyst Action: Jonathan Kownator, analyst at Goldman Sachs, reiterates coverage on [Klepierre (ex Compagnie Fonciere Klepierre) (KLPEF)]( in the Financial sector with a Buy rating and a price target of $29.38 (4 days ago). [TipRanks.com]( also reports that [Klepierre (ex Compagnie Fonciere Klepierre)]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $26.77. The target pricing ranges from a high forecast of $29.43 down to a low forecast of $24.80. [Klepierre (ex Compagnie Fonciere Klepierre) (KLPEF)](’s last closing price was $22.04 which would put the average price target at 21.47% upside. Here are 3rd party ratings for [KLPEF](: - TipRanks.com: Moderate Buy - TradingView.com: n/a (possibly response change) - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 32% (171 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [FDA News: The 1,788% Catalyst?]( Recent FDA News Propel This Little-Known Pharma Stock 1,788% in Early 2023? --------------------------------------------------------------- And there you have it... Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software